Patents Assigned to Insmed Inc.
  • Methods for treating lung cancer using insulin-like growth factor binding protein-3
    Publication number: 20040127411
    Abstract: The present invention relates generally to the use of Insulin like Growth Factor Binding Protein-3 (IGFBP-3) as an anti-neoplastic agent. More particularly, the invention relates to the use of IGFBP-3 in the treatment of patients with lung cancer.
    Type: Application
    Filed: September 11, 2003
    Publication date: July 1, 2004
    Applicant: Insmed, Inc.
    Inventor: Brian Leyland-Jones
  • Pharmaceutical formulations for IGF/IGFBP
    Publication number: 20030087806
    Abstract: New pharmaceutical formulations for IGF/IGFBP complex are disclosed. IGF/IGFBP complex, preferably rhIGF-I/IGFBP-3 complex is formulated with bulking agents and optionally buffer salts, but without added osmolyte salts. Also disclosed are lyophilized formulations for IGF/IGFBP complex.
    Type: Application
    Filed: August 20, 2002
    Publication date: May 8, 2003
    Applicant: Insmed Inc.
    Inventors: Stephen Danko, David Passmore, Yasushi Ogawa